Form D · Pharmaceuticals
ZETAGEN THERAPEUTICS, INC.
Syracuse, NY · CIK 0001730728
Offering snapshot reported Nov 12, 2025 · SEC filing
- Reported sold
- $12.9M Offering amount: $13M
- Investors reported
- 35 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 31, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$83,186 → $12,908,022
- Reported investors1 → 35
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2025 | Amendment | $12,908,022 | $12,824,836vs Jan 23, 2025 | 35 | SEC filing |
| Jan 23, 2025 | Initial | $83,186 | No comparison | 1 | SEC filing |
| Feb 6, 2023 | Initial | $9,634,360 | No comparison | 44 | SEC filing |
| Dec 27, 2019 | Initial | $840,000 | No comparison | 4 | SEC filing |
| Dec 26, 2018 | Initial | $1,000,000 | No comparison | 30 | SEC filing |
| Feb 13, 2018 | Initial | $1,726,000 | No comparison | 47 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-536037
Source: Form D, filed Nov 12, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Donald Brown | Director |
| Peter B. Finn | Executive |
| Ashok Kaveeshwar | Director |
| Joe C Loy | Director, Executive |
| Nikhil Thakur, Md | Director, Executive |
| David Tischler | Director, Executive |
| Richard Warburg | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:Syracuse, NY, 13210
Phone: 315-475-2200